Literature DB >> 11148523

Surfactant and surfactant inhibitors in meconium aspiration syndrome.

P A Dargaville1, M South, P N McDougall.   

Abstract

Surfactant indices and inhibitors were measured in lung lavage fluid from 8 infants with meconium aspiration syndrome (MAS) who were receiving mechanical ventilation and 11 healthy control subjects. Surfactant phospholipid and surfactant protein A content in MAS was not different from that of control subjects, but concentrations of total protein, albumin, and membrane-derived phospholipid were elevated. All infants with MAS had hemorrhagic pulmonary edema. These findings reinforce the notion of MAS as a toxic pneumonitis with epithelial disruption and proteinaceous exudation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11148523     DOI: 10.1067/mpd.2001.109602

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

Review 1.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-02       Impact factor: 2.253

3.  Recommendations for neonatal surfactant therapy.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-02       Impact factor: 2.253

4.  Respiratory distress including meconium aspiration syndrome in vigorous neonates born through meconium stained amniotic fluid: incidence, onset, severity and predictors at birth.

Authors:  S N Singh; Roli Srivastava; Anita Singh; M Tahazzul; Mala Kumar; Chandra Kanta; S Chandra
Journal:  Indian J Pediatr       Date:  2012-11-28       Impact factor: 1.967

5.  Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.

Authors:  Daniele De Luca; Angelo Minucci; Domenico Tripodi; Marco Piastra; Domenico Pietrini; Cecilia Zuppi; Giorgio Conti; Virgilio P Carnielli; Ettore Capoluongo
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

6.  Postnatal causes and severity of persistent pulmonary Hypertension of Newborn.

Authors:  Muhammad Sohail Arshad; Mudasser Adnan; Hafiz Muhammad Anwar-Ul-Haq; Arif Zulqarnain
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

7.  Update on PPHN: mechanisms and treatment.

Authors:  Jayasree Nair; Satyan Lakshminrusimha
Journal:  Semin Perinatol       Date:  2014-03       Impact factor: 3.300

Review 8.  Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.

Authors:  G Ganesh Konduri; U Olivia Kim
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

9.  Persistent pulmonary hypertension of non cardiac cause in a neonatal intensive care unit.

Authors:  Gustavo Rocha; Maria João Baptista; Hercília Guimarães
Journal:  Pulm Med       Date:  2012-05-09

10.  Respiratory support in meconium aspiration syndrome: a practical guide.

Authors:  Peter A Dargaville
Journal:  Int J Pediatr       Date:  2012-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.